XVIVO Perfusion AB (XVIPF)
Market Closed
14 Oct, 08:00 PM
$
21. 80
0
0%
$
718.53M Market Cap
384.18 P/E Ratio
- Div Yield
592 Volume
1.4 Eps
$ 21.8
Previous Close Want to track XVIPF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
XVIVO Perfusion AB (XVIPF) Statistics
Valuation metrics
Market Cap 718.53M
Enterprise value 6.56B
Trailing P/E (ttm) 76.16
Forward P/E -
PEG ratio -3.69
Price/Sales (ttm) 7.53
Price/Book (mrq) 3.06
Enterprise Value/Revenue 7.32
Enterprise Value/EBITDA 34.62
Overview
Shares outstanding 31.5M
Float 25.13M
Shares short -
% Held by insiders 0.08%
% Held by institutions 0.6%
Average volume (10 days) 88
Average volume (90 days) 119
Price summary
52-Week low 16.98
52-Week high 30.95
Beta 1.4
50-Day moving average 27.53
200-Day moving average 26.14
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.1%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.04%
Income Statement
Revenue (ttm) 812.16M
Revenue per share (ttm) 28.42
Quarterly revenue growth (yoy) -0.01%
Gross profit (ttm) 599.49M
EBITDA 85.93M
Net income to common (ttm) 25.16M
Diluted EPS (ttm) 2.81
Quarterly earnings growth (yoy) -0.13%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.68
Total debt (mrq) 124.72M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.86%
Book value per share (mrq) 69.85
Cash Flow
Cash flow statement -15.76M
Levered free cash flow (LFCF) -18.5M
2026 © Marketlog. All Rights Reserved.
